FDA adds rare vision-loss warning to popular GLP-1 drugs

FDA adds warning about rare vision loss to popular GLP-1s

The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning about a rare condition causing vision loss to the drugs' labels.

GLP-1 drugs must have new warning label over incurable blindness condition, says FDA

The Food and Drug Administration warned Monday that GLP-1 drugs may raise the risk of a rare but serious condition that can lead to permanent blindness.

FDA tells GLP-1 makers to warn of potential vision loss side effect

The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”

GLP-1 drugs to include new warning about rare eye condition causing sudden blindness, FDA says

The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and pills linked to a rare eye condition that can cause sudden blindness.

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic.